DNA shareholder files to sell 2,200 Class A shares on NYSE

A holder of Class A shares of DNA has filed a notice of proposed sale under Rule 144.

Rhea-AI Filing Summary

A holder of Class A shares of DNA has filed a notice of proposed sale under Rule 144. The filing covers 2,200 Class A shares to be sold through Fidelity Brokerage Services LLC, with an indicated aggregate market value of 20,152.00. The shares are listed on the NYSE, and the approximate sale date given is 01/07/2026. These 2,200 shares were acquired on 10/19/2022 through restricted stock vesting from the issuer as compensation. The filing notes that there are 48,523,595 Class A shares outstanding. Over the prior three months, the same seller, Austin Che, reported three separate sales of 2,200 Class A shares each, with gross proceeds of 33,462.00, 18,700.00, and 20,988.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for DNA disclose?

The Form 144 discloses that a shareholder plans to sell 2,200 Class A shares of DNA on the NYSE, with an indicated aggregate market value of 20,152.00.

How many DNA Class A shares are proposed to be sold and through which broker?

The notice covers 2,200 Class A shares of DNA to be sold through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

When were the DNA shares being sold under this Form 144 originally acquired and how?

The 2,200 Class A shares were acquired on 10/19/2022 via restricted stock vesting from the issuer, with the consideration described as compensation.

How many DNA Class A shares are outstanding according to this filing?

The filing states that 48,523,595 Class A shares of DNA were outstanding at the time referenced.

Who is the seller in the recent DNA Form 144 and what prior sales were reported?

The seller is Austin Che, listed at 27 Drydock Avenue, 8th Floor, Boston, MA 02210. Over the past three months, this person sold 2,200 Class A shares on 10/08/2025, 11/12/2025, and 12/10/2025, with gross proceeds of 33,462.00, 18,700.00, and 20,988.00, respectively.

On which exchange are the DNA shares in this Form 144 listed?

The filing identifies the securities as listed on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 10:09 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001882820
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ginkgo Bioworks Holdings, Inc.
SEC File Number	001-40097
Address of Issuer	27 DRYDOCK AVENUE 8TH FLOOR BOSTON MASSACHUSETTS 02210
Phone	(877) 442-5362
Name of Person for Whose Account the Securities are To Be Sold	Che Austin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	20152.00	48523595	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	10/19/2022	Restricted Stock Vesting	Issuer			2200	10/19/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	10/08/2025	2200	33462.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	11/12/2025	2200	18700.00
Austin Che 27 Drydock Avenue 8th Floor Boston MA 02210	Class A	12/10/2025	2200	20988.00

144: Remarks and Signature

Remarks
Date of Notice	01/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Austin Che
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)